• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Antibiotic Use and Vaccine Antibody Levels.抗生素使用与疫苗抗体水平。
Pediatrics. 2022 May 1;149(5). doi: 10.1542/peds.2021-052061.
2
Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination.同时接种灭活脊髓灰质炎病毒疫苗导致对白喉-破伤风-无细胞百日咳/ b型流感嗜血杆菌联合疫苗的抗多聚核糖基核糖醇磷酸反应减弱。
Pediatr Infect Dis J. 2000 May;19(5):417-23. doi: 10.1097/00006454-200005000-00006.
3
New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).新联合疫苗:DTaP-IPV(金鑫宁)和 DTaP-IPV/Hib(沛儿)。
Ann Pharmacother. 2010 Mar;44(3):515-23. doi: 10.1345/aph.1M468.
4
Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.白喉、破伤风类毒素、无细胞百日咳、乙型肝炎和灭活脊髓灰质炎疫苗与7价肺炎球菌结合疫苗及b型流感嗜血杆菌结合疫苗联合接种的免疫原性和安全性。
J Pediatr. 2007 Jul;151(1):43-9, 49.e1-2. doi: 10.1016/j.jpeds.2007.02.013.
5
Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial.母亲接种白喉-破伤风-无细胞百日咳疫苗对幼儿百日咳加强免疫反应的影响:一项随机试验的随访。
Vaccine. 2021 Mar 12;39(11):1598-1608. doi: 10.1016/j.vaccine.2021.02.001. Epub 2021 Feb 19.
6
Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.五价疫苗与美国婴幼儿中单独接种许可等效疫苗相比的安全性和免疫原性以及学龄前加强剂量前抗体的持久性:一项随机临床试验。
Pediatrics. 2009 Jan;123(1):301-12. doi: 10.1542/peds.2007-3317.
7
Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccine.白喉、破伤风和百日咳类毒素与灭活脊髓灰质炎疫苗联合使用时,作为b型流感嗜血杆菌结合疫苗的稀释剂或与之同时接种时的免疫原性和反应原性。
Vaccine. 2001 Aug 14;19(31):4396-403. doi: 10.1016/s0264-410x(01)00199-2.
8
Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United States.加拿大百日咳和b型流感嗜血杆菌疾病的流行病学情况:仅使用白喉-破伤风-无细胞百日咳-灭活脊髓灰质炎病毒-b型流感嗜血杆菌儿科联合疫苗和青少年-成人破伤风-白喉-无细胞百日咳疫苗的影响,对美国疾病预防的启示
Pediatr Infect Dis J. 2009 Jun;28(6):521-8. doi: 10.1097/INF.0b013e318199d2fc.
9
Absence of a significant interaction between a Haemophilus influenzae conjugate vaccine combined with a diphtheria toxoid, tetanus toxoid and acellular pertussis vaccine in the same syringe and inactivated polio vaccine.在同一注射器中联合使用的流感嗜血杆菌结合疫苗与白喉类毒素、破伤风类毒素和无细胞百日咳疫苗,与灭活脊髓灰质炎疫苗之间不存在显著相互作用。
Pediatr Infect Dis J. 2000 Aug;19(8):710-7. doi: 10.1097/00006454-200008000-00008.
10
Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age.
Chang Gung Med J. 2003 May;26(5):315-22.

引用本文的文献

1
Antibiotics, microbiota and the calibration of infant vaccine responses.抗生素、微生物群与婴儿疫苗反应的校准
Nat Immunol. 2025 Jun;26(6):810-811. doi: 10.1038/s41590-025-02169-9.
2
Antibiotic-induced gut microbiome perturbation alters the immune responses to the rabies vaccine.抗生素诱导的肠道微生物群扰动会改变对狂犬病疫苗的免疫反应。
Cell Host Microbe. 2025 May 14;33(5):705-718.e5. doi: 10.1016/j.chom.2025.03.015. Epub 2025 Apr 18.
3
Bifidobacteria support optimal infant vaccine responses.双歧杆菌有助于婴儿获得最佳的疫苗反应。
Nature. 2025 May;641(8062):456-464. doi: 10.1038/s41586-025-08796-4. Epub 2025 Apr 2.
4
Lifelong partners: Gut microbiota-immune cell interactions from infancy to old age.终身伴侣:从婴儿期到老年期的肠道微生物群与免疫细胞相互作用
Mucosal Immunol. 2025 Jun;18(3):509-523. doi: 10.1016/j.mucimm.2025.01.006. Epub 2025 Jan 23.
5
Systematic review of the impact of intestinal microbiota on vaccine responses.肠道微生物群对疫苗反应影响的系统评价。
NPJ Vaccines. 2024 Dec 20;9(1):254. doi: 10.1038/s41541-024-01000-0.
6
The role of the gut microbiota in regulating responses to vaccination: current knowledge and future directions.肠道微生物群在调节疫苗接种反应中的作用:当前认知与未来方向
FEBS J. 2025 Mar;292(6):1480-1499. doi: 10.1111/febs.17241. Epub 2024 Aug 5.
7
Effect of Supplementation in Newborns Born from Cesarean Section on Atopy, Respiratory Tract Infections, and Dyspeptic Syndromes: A Multicenter, Randomized, and Controlled Clinical Trial.剖宫产新生儿补充剂对特应性、呼吸道感染和消化不良综合征的影响:一项多中心、随机对照临床试验
Microorganisms. 2024 May 28;12(6):1093. doi: 10.3390/microorganisms12061093.
8
Are the first 1,000 days of life a neglected vital period to prevent the impact on maternal and infant morbimortality of infectious diseases in Latin America? Proceedings of a workshop of experts from the Latin American Pediatric Infectious Diseases Society, SLIPE.生命的最初1000天是预防传染病对拉丁美洲母婴发病率和死亡率产生影响的一个被忽视的关键时期吗?拉丁美洲儿科传染病学会(SLIPE)专家研讨会会议记录。
Front Pediatr. 2023 Nov 30;11:1297177. doi: 10.3389/fped.2023.1297177. eCollection 2023.
9
Variability of Vaccine Responsiveness in Young Children.幼儿疫苗反应性的变异性
J Infect Dis. 2024 Jun 14;229(6):1856-1865. doi: 10.1093/infdis/jiad524.
10
PRL2020: Antibiotic-Resistant Profile and Genomic Detection of Antibiotic Resistance Determinants.PRL2020:抗生素耐药谱及抗生素耐药决定因素的基因组检测
Microorganisms. 2023 Jun 24;11(7):1649. doi: 10.3390/microorganisms11071649.

本文引用的文献

1
Pneumonia, Sinusitis, Influenza and Other Respiratory Illnesses in Acute Otitis Media-Prone Children.急性中耳炎易感儿童中的肺炎、鼻窦炎、流感和其他呼吸道疾病。
Pediatr Infect Dis J. 2021 Nov 1;40(11):975-980. doi: 10.1097/INF.0000000000003228.
2
Nasopharyngeal microbiome analyses in otitis-prone and otitis-free children.鼻咽微生物组分析在易患中耳炎和无中耳炎儿童中的应用。
Int J Pediatr Otorhinolaryngol. 2021 Apr;143:110629. doi: 10.1016/j.ijporl.2021.110629. Epub 2021 Jan 21.
3
Nasopharyngeal colonization with pathobionts is associated with susceptibility to respiratory illnesses in young children.鼻咽部定植病原体与婴幼儿呼吸道疾病易感性有关。
PLoS One. 2020 Dec 11;15(12):e0243942. doi: 10.1371/journal.pone.0243942. eCollection 2020.
4
Immunologic dysfunction contributes to the otitis prone condition.免疫功能障碍导致易患中耳炎。
J Infect. 2020 Jun;80(6):614-622. doi: 10.1016/j.jinf.2020.03.017. Epub 2020 Mar 20.
5
Pediatric Antibiotic Prescribing in China According to the 2019 World Health Organization Access, Watch, and Reserve (AWaRe) Antibiotic Categories.根据 2019 年世界卫生组织的获取、监测和保留(AWaRe)抗生素类别,中国儿科抗生素处方情况。
J Pediatr. 2020 May;220:125-131.e5. doi: 10.1016/j.jpeds.2020.01.044. Epub 2020 Feb 21.
6
Updates on immunologic correlates of vaccine-induced protection.疫苗诱导保护的免疫相关性研究进展。
Vaccine. 2020 Feb 24;38(9):2250-2257. doi: 10.1016/j.vaccine.2019.10.046. Epub 2019 Nov 22.
7
Overtesting and overtreatment-statement from the European Academy of Paediatrics (EAP).过度检查和过度治疗——欧洲儿科学会(EAP)的声明。
Eur J Pediatr. 2019 Dec;178(12):1923-1927. doi: 10.1007/s00431-019-03461-1. Epub 2019 Sep 10.
8
Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans.抗生素驱动的肠道微生物组扰动改变了人类对疫苗的免疫反应。
Cell. 2019 Sep 5;178(6):1313-1328.e13. doi: 10.1016/j.cell.2019.08.010.
9
Early-Life Antibiotic-Driven Dysbiosis Leads to Dysregulated Vaccine Immune Responses in Mice.早期生活抗生素驱动的失调导致小鼠疫苗免疫反应失调。
Cell Host Microbe. 2018 May 9;23(5):653-660.e5. doi: 10.1016/j.chom.2018.04.009.
10
Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors.减毒活、口服轮状病毒疫苗在低收入环境中表现不佳的原因和促成因素。
Expert Rev Vaccines. 2018 Feb;17(2):145-161. doi: 10.1080/14760584.2018.1418665. Epub 2017 Dec 29.

抗生素使用与疫苗抗体水平。

Antibiotic Use and Vaccine Antibody Levels.

机构信息

Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York.

School of Mathematical Sciences, College of Science, Rochester Institute of Technology, Rochester, New York.

出版信息

Pediatrics. 2022 May 1;149(5). doi: 10.1542/peds.2021-052061.

DOI:10.1542/peds.2021-052061
PMID:35474546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9648114/
Abstract

BACKGROUND

The majority of children are prescribed antibiotics in the first 2 years of life while vaccine-induced immunity develops. Researchers have suggested a negative association of antibiotic use with vaccine-induced immunity in adults, but data are lacking in children.

METHODS

From 2006 to 2016, children aged 6 to 24 months were observed in a cohort study. A retrospective, unplanned secondary analysis of the medical record regarding antibiotic prescriptions and vaccine antibody measurements was undertaken concurrently. Antibody measurements relative to diphtheria-tetanus-acellular pertussis (DTaP), inactivated polio (IPV), Haemophilus influenzae type b (Hib), and pneumococcal conjugate (PCV) vaccines were made.

RESULTS

In total, 560 children were compared (342 with and 218 without antibiotic prescriptions). Vaccine-induced antibody levels to several DTaP and PCV antigens were lower (P < .05) in children given antibiotics. A higher frequency of vaccine-induced antibodies below protective levels in children given antibiotics occurred at 9 and 12 months of age (P < .05). Antibiotic courses over time was negatively associated with vaccine-induced antibody levels. For each antibiotic course the child received, prebooster antibody levels to DTaP antigens were reduced by 5.8%, Hib by 6.8%, IPV by 11.3%, and PCV by 10.4% (all P ≤ .05), and postbooster antibody levels to DTaP antigens were reduced by 18.1%, Hib by 21.3%, IPV by 18.9%, and PCV by 12.2% (all P < .05).

CONCLUSIONS

Antibiotic use in children <2 years of age is associated with lower vaccine-induced antibody levels to several vaccines.

摘要

背景

在疫苗诱导免疫发展的前 2 年,大多数儿童都被开了抗生素。研究人员提出,抗生素的使用与成人的疫苗诱导免疫呈负相关,但儿童的数据却缺乏。

方法

2006 年至 2016 年,对 6 至 24 个月大的儿童进行了队列研究。同时对病历中关于抗生素处方和疫苗抗体测量的回顾性、无计划的二次分析进行了回顾性、无计划的二次分析。对与白喉-破伤风-无细胞百日咳(DTaP)、灭活脊髓灰质炎(IPV)、流感嗜血杆菌 b 型(Hib)和肺炎球菌结合(PCV)疫苗相关的抗体测量进行了分析。

结果

共比较了 560 名儿童(342 名服用抗生素,218 名未服用抗生素)。接受抗生素治疗的儿童对几种 DTaP 和 PCV 抗原的抗体水平较低(P<0.05)。接受抗生素治疗的儿童在 9 个月和 12 个月时发生低于保护性水平的疫苗诱导抗体的频率更高(P<0.05)。随着时间的推移,抗生素疗程与疫苗诱导的抗体水平呈负相关。对于儿童每次接受的抗生素疗程,DTaP 抗原的预加强抗体水平降低 5.8%,Hib 降低 6.8%,IPV 降低 11.3%,PCV 降低 10.4%(均 P≤0.05),DTaP 抗原的后加强抗体水平降低 18.1%,Hib 降低 21.3%,IPV 降低 18.9%,PCV 降低 12.2%(均 P<0.05)。

结论

2 岁以下儿童使用抗生素与几种疫苗诱导的抗体水平较低有关。